Drugmakers to Benefit From Obama's Brain Initiative

April 2 (Bloomberg) -- President Barack Obama announced a U.S. campaign that may lead to new treatments for some of the least understood brain disorders, benefiting efforts by Pfizer, Roche and Eli Lilly. Shannon Pettypiece reports on Bloomberg Television's "Money Moves." (Source: Bloomberg)

Soylent: The Food of the Future?
08:57 - Rob Rhinehart, Soylent's chief executive officer, discusses the company's quest to disrupt the food industry. He speaks with Bloomberg's Emily Chang on "Bloomberg West." (Source: Bloomberg)
  • Full Show: What'd You Miss? (07/22)
  • Should More Filmmakers Use Virtual Reality Technology?
  • How Important Is the Smartwatch Market to Apple?